GLP-1 RAs and Dietary Intake and Body Composition
Longitudinal Effects of GLP-1 Receptor Agonists on Dietary Intake and Body Composition
To assess longitudinal changes in dietary intake, body composition and metabolism with GLP-1 RA use.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Locations
-
-
Ohio
-
Athens, Ohio, United States, 45701
- Recruiting
- Exercise Physiology Lab
-
Contact:
- Angela Hillman, PhD
- Phone Number: 740-593-0153
- Email: hillman@ohio.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
People taking GLP-1 RA medications
Description
Inclusion Criteria:
- Currently taking GLP-1 medications and have been taking them for less than a month
- between the ages of 18-75 years
Exclusion Criteria:
- Not between the ages of 18-75 years
- Not currently using GLP-1 medications
- Have been using GLP-1 medications for 1 month or longer
- Currently pregnant
- Currently nursing
- Bariatric surgery in the last 3 months
- Have an implanted cardiac device, such as a pacemaker or defibrillator
- Not willing to have a DEXA (full body x-ray) at the start and end of the 12 week study period
- Not willing to have a bioelectrical impedance body composition scan at the start and every 2 weeks during the 12 week study period
- Not willing to have your resting metabolism measured at the start and end of the 12 week study period
- Not willing to track your diet at the beginning and end of the study
- Not willing to complete surveys assessing depression, food noise and disordered eating
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
change in body mass
Time Frame: 12 weeks
|
change in body weight measured in kg using BIA and DEXA |
12 weeks
|
|
change in skeletal muscle mass
Time Frame: 12 weeks
|
change in skeletal muscle mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in body fat mass
Time Frame: 12 weeks
|
change in body fat mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in resting metabolism
Time Frame: 12 weeks
|
change in resting metabolic rate in kcals/day as measured via indirect calorimetry |
12 weeks
|
|
change in substrate utilization rates
Time Frame: 12 weeks
|
change in resting carbohydrate and fat oxidation rates as measured via indirect calorimetry |
12 weeks
|
|
change in bone mineral content
Time Frame: 12 weeks
|
change in bone mineral content measured via DEXA and BIA |
12 weeks
|
|
change in bone mineral density
Time Frame: 12 weeks
|
change in bone mineral density measured via DEXA |
12 weeks
|
|
change in total daily caloric intake
Time Frame: 12 weeks
|
change in total daily caloric intake measured via 24 hour food diary |
12 weeks
|
|
change in daily carbohydrate intake
Time Frame: 12 weeks
|
change in daily carbohydrate intake measured via 24 hour food diary |
12 weeks
|
|
change in daily fat intake
Time Frame: 12 weeks
|
change in daily fat intake measured via 24 hour food diary |
12 weeks
|
|
change in daily protein intake
Time Frame: 12 weeks
|
change in daily protein intake measured via 24 hour food diary |
12 weeks
|
|
change in daily mineral intake
Time Frame: 12 weeks
|
change in daily mineral intake measured via 24 hour food diary |
12 weeks
|
|
change in daily vitamin intake
Time Frame: 12 weeks
|
change in daily vitamin intake measured via 24 hour food diary |
12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- IRB-FY26-568
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.